A Phase 1b/2, Randomized, Controlled, Open-Label Study Evaluating the Safety and Efficacy of ABBV-927 Administered in Combination with Modified FOLFIRINOX (mFFX) With or Without Budigalimab compared to mFFX in Subjects with Untreated Metastatic Pancreatic Adenocarcinoma

  • Harris, Marion (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date4/11/21 → 3/11/26

Keywords

  • treatment efficacy
  • treatment safety
  • pancreatic cancer
  • Phase 1 and 2 study